Ironwood Pharmaceuticals
IRWD
#6665
Rank
A$1.19 B
Marketcap
A$7.19
Share price
0.41%
Change (1 day)
50.10%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): A$0.30 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are A$0.38 Billion. In 2025 the company made an earning of A$0.10 Billion, an increase over its 2024 earnings that were of A$96.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.30 B193.16%
2025 A$0.10 B7.4%
2024 A$96.67 M-106.88%
2023 -A$1.41 Billion-475.59%
2022 A$0.37 B25.8%
2021 A$0.29 B84.32%
2020 A$0.16 B84.69%
2019 A$87.4 M-125.13%
2018 -A$0.35 Billion100.62%
2017 -A$0.18 Billion43.12%
2016 -A$0.13 Billion-42.73%
2015 -A$0.22 Billion-24.76%
2014 -A$0.29 Billion-30.49%
2013 -A$0.41 Billion275.65%
2012 -A$0.11 Billion11.56%
2011 -A$96.53 Million9.38%
2010 -A$88.25 Million-15.21%
2009 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
A$22.37 B 7,176.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-A$0.23 Billion-173.83%๐Ÿ‡บ๐Ÿ‡ธ USA